Genetically-Engineered Models: The Value of Precious GEMs - a podcast by Drug Discovery World (DDW)
from 2019-04-09T12:00
Genetically-engineered animal models (GEMs) are critical tools for drug discovery and development, but intellectual property (IP) concerns can complicate access.
As pharma and biotech increasingly outsource R&D activities to universities, careful scrutiny is required to ensure adherence to IP restrictions on research tools across those collaborative activities. As demonstrated by recent high-profile lawsuits, the stakes are higher than ever for all parties.
Despite improvements to in vitro assays, animal models are a critical part of preclinical drug discovery and development and will remain so for the foreseeable future. In particular, GEMs are specialised reagents with value across R&D stages.
Original article by Dr Megan M. MacBride
If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
https://www.ddw-online.com/media/32/133162/(3)-genetically-engineered-models.pdf
For more information on Drug Discovery World, head to:
Further episodes of The Drug Discovery World Podcast
Further podcasts by Drug Discovery World (DDW)
Website of Drug Discovery World (DDW)